EPIC-Norfolk Publications Database

Testing for a causal role of thyroid hormone measurements within the normal range on human metabolism and diseases: a systematic Mendelian randomization.

Alwan H, Luan J, Williamson A, Carrasco-Zanini J, Stewart ID, Wareham NJ, Langenberg C, and Pietzner M

EBioMedicine. Aug 2024

(DOI : 10.1016/j.ebiom.2024.105306)

Proteomic signatures improve risk prediction for common and rare diseases.

Carrasco-Zanini J, Pietzner M, Davitte J, Surendran P, Croteau-Chonka DC, Robins C, Torralbo A, Tomlinson C, Grünschläger F, Fitzpatrick N, Ytsma C, Kanno T, Gade S, Freitag D, Ziebell F, Haas S, Denaxas S, Betts JC, Wareham NJ, Hemingway H, Scott RA, and Langenberg C

Nature medicine. Jul 2024

(DOI : 10.1038/s41591-024-03142-z)

Proteomic prediction of diverse incident diseases: a machine learning-guided biomarker discovery study using data from a prospective cohort study.

Carrasco-Zanini J, Pietzner M, Koprulu M, Wheeler E, Kerrison ND, Wareham NJ, and Langenberg C

The Lancet. Digital health. Jun 2024

(DOI : 10.1016/S2589-7500(24)00087-6)

Multi-omic prediction of incident type 2 diabetes.

Carrasco-Zanini J, Pietzner M, Wheeler E, Kerrison ND, Langenberg C, and Wareham NJ

Diabetologia. Oct 2023

(DOI : 10.1007/s00125-023-06027-x)

Proteogenomic links to human metabolic diseases.

Koprulu M, Carrasco-Zanini J, Wheeler E, Lockhart S, Kerrison ND, Wareham NJ, Pietzner M, and Langenberg C

Nature metabolism. Feb 2023

(DOI : 10.1038/s42255-023-00753-7)

Proteomic signatures for identification of impaired glucose tolerance.

Carrasco-Zanini J, Pietzner M, Lindbohm JV, Wheeler E, Oerton E, Kerrison N, Simpson M, Westacott M, Drolet D, Kivimaki M, Ostroff R, Williams SA, Wareham NJ, and Langenberg C

Nature medicine. Nov 2022

(DOI : 10.1038/s41591-022-02055-z)